Bausch Health Companies

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BHC and other ETFs, options, and stocks.

About BHC

Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: Salix, International, Solta Medical, Diversified Products, and Bausch + Lomb. 

CEO
Thomas J. Appio
CEOThomas J. Appio
Employees
20,300
Employees20,300
Headquarters
Laval, Québec
HeadquartersLaval, Québec
Founded
1994
Founded1994
Employees
20,300
Employees20,300

BHC Key Statistics

Market cap
2.25B
Market cap2.25B
Price-Earnings ratio
-1.99
Price-Earnings ratio-1.99
Dividend yield
—
Dividend yield—
Average volume
1.91M
Average volume1.91M
High today
$5.91
High today$5.91
Low today
$5.73
Low today$5.73
Open price
$5.88
Open price$5.88
Volume
1.56M
Volume1.56M
52 Week high
$8.00
52 Week high$8.00
52 Week low
$4.33
52 Week low$4.33

Stock Snapshot

The current Bausch Health Companies(BHC) stock price is $5.85, with a market capitalization of 2.25B. The stock trades at a price-to-earnings (P/E) ratio of -1.99.

As of 2026-10-14, Bausch Health Companies(BHC) stock has fluctuated between $5.73 and $5.91. The current price stands at $5.85, placing the stock +2.1% above today's low and -1.0% off the high.

The Bausch Health Companies(BHC)'s current trading volume is 1.56M, compared to an average daily volume of 1.91M.

During the past year, Bausch Health Companies(BHC) stock moved between $4.33 at its lowest and $8.00 at its peak.

During the past year, Bausch Health Companies(BHC) stock moved between $4.33 at its lowest and $8.00 at its peak.

BHC News

TipRanks 2d
Bausch Health reports results from study of pathway for cirrhosis management

Bausch Health (BHC) Companies and its gastroenterology business, Salix Pharmaceuticals, announced results from a multicenter pilot study evaluating a standardiz...

TipRanks 2d
Bausch + Lomb names Thomas Appio as interim CEO

Bausch + Lomb (BLCO) and its parent company, Bausch Health (BHC), announced that Bausch + Lomb Board of Directors Chairman Thomas Appio has been appointed inter...

Analyst ratings

83%

of 6 ratings
Buy
16.7%
Hold
83.3%
Sell
0%

People also own

Based on the portfolios of people who own BHC. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.